Warren Regelmann

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis

The Journal of Pediatrics · 2007 · 364 citations

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

The Lancet Respiratory Medicine · 2016 · 272 citations